Effect of Akti‑2 on sperm motility, capacitation and acrosome reaction in a mouse model

Quan,Yanmei; Liu,Qiang

doi:10.3892/br.2016.627

Effect of Akti‑2 on sperm motility, capacitation and acrosome reaction in a mouse model

Authors:
- Yanmei Quan
- Qiang Liu
View Affiliations

Affiliations: Shanghai Key Laboratory of Reproductive Medicine, Department of Anatomy, Histology and Embryology, Faculty of Basic Medicine, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, P.R. China
Published online on: March 7, 2016 https://doi.org/10.3892/br.2016.627
Pages: 578-582

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effect of the Akt inhibitor, Akti‑2, on the sperm motility and acrosome reaction in mice. Mature sperms from the adult mice, aged 8 weeks, were co‑incubated with Akti‑2 for ~30 min at 37˚C in 5% CO2, and the sperm viability was assessed by eosin‑nigrosin staining. The sperm total and progressive motility were analyzed by computer‑aided sperm analysis. In addition, the acrosome reaction of sperms was detected by the acid phosphatase assay, Coomassie Brilliant Blue staining and fluorescein‑isothiocyanate conjugated pisum sativum lectin staining, respectively. Compared with the control (dimethyl sulfoxide), Akti‑2 had no effect on sperm viability, but it suppressed the total and progressive motility significantly. Furthermore, the capacitation‑associated protein tyrosine phosphorylation and the acrosome reaction induced by calcium ionophore A23187 could be suppressed by Akti‑2. These experiments confirmed that Akti‑2 significantly impaired the sperm functions, including motility, capacitation and acrosome reaction, and provide the proof for its potential in male reproductive toxicity.

View Figures

View References

1	West KA, Castillo SS and Dennis PA: Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist Updat. 5:234–248. 2002. View Article : Google Scholar : PubMed/NCBI
2	Staal SP: Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: Amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci USA. 84:5034–5037. 1987. View Article : Google Scholar : PubMed/NCBI
3	Hanks SK and Hunter T: Protein kinases 6. The eukaryotic protein kinase superfamily: Kinase (catalytic) domain structure and classification. FASEB J. 9:576–596. 1995.PubMed/NCBI
4	Zinda MJ, Johnson MA, Paul JD, Horn C, Konicek BW, Lu ZH, Sandusky G, Thomas JE, Neubauer BL, Lai MT and Graff JR: AKT-1, −2, and −3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon. Clin Cancer Res. 7:2475–2479. 2001.PubMed/NCBI
5	Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU and Brady JN: Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene. 24:6719–6728. 2005. View Article : Google Scholar : PubMed/NCBI
6	Song G, Ouyang G and Bao S: The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med. 9:59–71. 2005. View Article : Google Scholar : PubMed/NCBI
7	Lindsley CW, Zhao Z, Leister WH, Robinson RG, Barnett SF, Defeo-Jones D, Jones RE, Hartman GD, Huff JR, Huber HE and Duggan ME: Allosteric Akt (PKB) inhibitors: Discovery and SAR of isozyme selective inhibitors. Bioorg Med Chem Lett. 15:761–764. 2005. View Article : Google Scholar : PubMed/NCBI
8	Cherrin C, Haskell K, Howell B, Jones R, Leander K, Robinson R, Watkins A, Bilodeau M, Hoffman J, Sanderson P, et al: An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivo. Cancer Biol Ther. 9:493–503. 2010. View Article : Google Scholar : PubMed/NCBI
9	Pietrobon EO, Domínguez LA, Vincenti AE, Burgos MH and Fornés MW: Detection of the mouse acrosome reaction by acid phosphatase. Comparison with chlortetracycline and electron microscopy. J Androl. 22:96–103. 2001.PubMed/NCBI
10	Visconti PE, Bailey JL, Moore GD, Pan D, Olds-Clarke P and Kopf GS: Capacitation of mouse spermatozoa. I. Correlation between the capacitation state and protein tyrosine phosphorylation. Development. 121:1129–1137. 1995.PubMed/NCBI
11	Barret AJ and Heath MF: Lysosomal enzymes. Lysosomes: A Laboratory Handbook. Dingle JT: (2nd). Elsevier/North-Holland Biomedical Press. (Amsterdam). 19–145. 1977.
12	Belmonte SA, Challa A, Gutierrez LS, Bertini F and Sosa MA: alpha-Mannosidase from rat epididymal fluid is a ligand for phosphomannosyl receptors on the sperm surface. Int J Androl. 21:277–282. 1998. View Article : Google Scholar : PubMed/NCBI
13	Aarons D, Boettger-Tong H, Holt G and Poirier GR: Acrosome reaction induced by immunoaggregation of a proteinase inhibitor bound to the murine sperm head. Mol Reprod Dev. 30:258–264. 1991. View Article : Google Scholar : PubMed/NCBI
14	Fichorova R and Anderson DJ: Use of sperm viability and acrosomal status assays in combination with immunofluorescence technique to ascertain surface expression of sperm antigens. J Reprod Immunol. 20:1–13. 1991. View Article : Google Scholar : PubMed/NCBI
15	Banihani S, Agarwal A, Sharma R and Bayachou M: Cryoprotective effect of L-carnitine on motility, vitality and DNA oxidation of human spermatozoa. Andrologia. 46:637–641. 2014. View Article : Google Scholar : PubMed/NCBI
16	Lan A and Du J: Potential role of Akt signaling in chronic kidney disease. Nephrol Dial Transplant. 30:385–394. 2015. View Article : Google Scholar : PubMed/NCBI
17	Sajithlal GB, Hamed HA, Cruickshanks N, Booth L, Tavallai S, Syed J, Grant S, Poklepovic A and Dent P: Sorafenib/regorafenib and phosphatidyl inositol 3 kinase/thymoma viral proto-oncogene inhibition interact to kill tumor cells. Mol Pharmacol. 84:562–571. 2013. View Article : Google Scholar : PubMed/NCBI
18	Hu C, Dadon T, Chenna V, Yabuuchi S, Bannerji R, Booher R, Strack P, Azad N, Nelkin BD and Maitra A: Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models. Mol Cancer Ther. 14:1532–1539. 2015. View Article : Google Scholar : PubMed/NCBI
19	Conti AI, Santoni M, Amantini C, Burattini L, Berardi R, Santoni G, Cascinu S and Muzzonigro G: Progress of molecular targeted therapies for advanced renal cell carcinoma. Biomed Res Int. 2013:4191762013. View Article : Google Scholar : PubMed/NCBI
20	Gonzalez-Angulo AM, Krop I, Akcakanat A, Chen H, Liu S, Li Y, Culotta KS, Tarco E, Piha-Paul S, Moulder-Thompson S, et al: SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer. J Natl Cancer Inst. 107:pii: dju4932015. View Article : Google Scholar
21	Fraser LR: Requirements for successful mammalian sperm capacitation and fertilization. Arch Pathol Lab Med. 116:345–350. 1992.PubMed/NCBI
22	Naz RK and Rajesh PB: Role of tyrosine phosphorylation in sperm capacitation/acrosome reaction. Reprod Biol Endocrinol. 2:752004. View Article : Google Scholar : PubMed/NCBI
23	Suarez SS: Control of hyperactivation in sperm. Hum Reprod Update. 14:647–657. 2008. View Article : Google Scholar : PubMed/NCBI